Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Expeditors International of Washington, Inc. | EW1 | Jan 10, 2025 | 109.30 | +0.18 |
Experian PLC | J2B | Jan 10, 2025 | 41.40 | +0.98 |
Experian Plc | J2BA | Jan 10, 2025 | 41.20 | +0.98 |
EXPERT SYSTEM S P A AZIONI ORDINARIE SENZA VALORE (NOMINALE | 3K2 | Jan 10, 2025 | 1.26 | +0.48 |
Exploits Discovery Corp | 634 | Jan 10, 2025 | 0.03 | +23.64 |
Exponent, Inc. | EP5 | Jan 10, 2025 | 86.94 | +1.00 |
ExpreS2ion Biotech Holding | 5JD0 | Jan 10, 2025 | 2.04 | 0.00 |
ExpreS2ion Biotech Holding | 5JD | Jan 10, 2025 | 0.07 | 0.00 |
Exro Technologies Inc | 1O2 | Jan 10, 2025 | 0.07 | -1.88 |
Exsitec | 1TI | Jan 10, 2025 | 11.45 | 0.00 |
Extendicare Inc | 5XE | Jan 10, 2025 | 6.70 | -0.74 |
Extra Space Storage Inc. | FG8 | Jan 10, 2025 | 142.80 | +0.25 |
Extreme Networks, Inc. | EXM | Jan 10, 2025 | 16.61 | -0.18 |
Exxaro Resources Ltd | LCQ | Jan 10, 2025 | 7.80 | +0.65 |
EXXON MOBIL CDR REG.S | XON | Jan 10, 2025 | 13.13 | 0.00 |
Exxon Mobil Corporation | XONA | Jan 10, 2025 | 103.96 | +0.04 |
EyePoint Pharmaceuticals, Inc. | PV3B | Jan 10, 2025 | 8.69 | +1.42 |
Ezaki Glico Co. Ltd. | 5EJ | Jan 10, 2025 | 27.60 | 0.00 |
EZCORP, Inc. - Class A Non-Voting | EZ2A | Jan 10, 2025 | 11.50 | 0.00 |
F Ramada-Investimentos SGPS S A | Y4E | Jan 10, 2025 | 6.94 | +0.87 |
F+C INVESTMENT TR LS-,25 | 0XW | Jan 10, 2025 | 13.00 | 0.00 |
F-Secure Corp | 3I6 | Jan 10, 2025 | 1.78 | 0.00 |
F. C. C. Co Ltd | FCV | Jan 10, 2025 | 19.20 | 0.00 |
F.N.B. Corporation | FN2 | Jan 10, 2025 | 13.60 | -0.73 |
F3 URANIUM CORP. NEW | GL7 | Jan 10, 2025 | 0.18 | +6.40 |
F5 Networks, Inc. | FFV | Jan 10, 2025 | 248.80 | -0.20 |
Fabasoft AG | FAA | Jan 10, 2025 | 16.25 | 0.00 |
Fabege | WILC | Jan 10, 2025 | 6.80 | +0.30 |
Fabrinet | FAN | Jan 10, 2025 | 222.30 | -1.11 |
Fabryka Farb I Lakierow Sniezka S. A | 695 | Jan 10, 2025 | 19.35 | +1.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.